1-3 of 3
Susanna Cappia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor

Bao Hoang, Patrick Frost, Yijiang Shi, Eileen Belanger, Angelica Benavides, Gholam Pezeshkpour, Susanna Cappia, Tommasina Guglielmelli, Joseph Gera, Alan Lichtenstein
Journal: Blood
Blood (2010) 116 (22): 4560–4568.
https://doi.org/10.1182/blood-2010-05-285726
Published: 2010
Includes: Supplemental data
Journal Articles

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, PhD, Roberta Merlini, MD, Elisa Bacillo, MD, Francesca Gay, MD, Paola Berchialla, PhD, Dario Gregori, PhD, Mauro Papotti, PhD, Antonio Palumbo, MD, Giuseppe Saglio, PhD
Journal: Blood
Blood (2008) 112 (11): 2716.
https://doi.org/10.1182/blood.V112.11.2716.2716
Published: 2008
Journal Articles

Activation of the mTOR Signaling Pathway in Multiple Myeloma Patients and Its Prognostic Significance.

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, MD, Roberta Merlini, MD, Stefano Mussino, MD, Elena Bacillo, MD, Enrico Bracco, PhD, Maurizio Papotti, PhD, Giuseppe Saglio, PhD
Journal: Blood
Blood (2007) 110 (11): 1493.
https://doi.org/10.1182/blood.V110.11.1493.1493
Published: 2007